BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 25, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 20, 2015
View Archived Issues
Pacific Therapeutics launches share offer
Read More
Cell Cure initiates phase I/II study of OpRegen in patients with dry AMD and geographic atrophy
Read More
Institut Pasteur Korea and Qurient report anti-TB compounds
Read More
Vaxin to acquire Immune Targeting Systems
Read More
Merck KGaA discloses new BTK inhibitors
Read More
Novartis reports SMN expression enhancers
Read More
Amarantus enters into Alzheimer's biomarker collaboration with Anavex Life Sciences
Read More
Servier and Vernalis patent novel Bcl-2 inhibitors
Read More
Metabolic Solutions Development divulges PPAR-sparing compounds
Read More
Neutrophil activation shows potential as a biomarker for ischemia and inflammation
Read More
Actavis proposes adopting Allergan as corporate name
Read More
Revlimid approved in E.U. for previously untreated multiple myeloma
Read More
MMP-12 knockdown protects BBB integrity and reduces permeability
Read More
Teva to study TV-45070 for post-herpetic neuralgia in phase IIb trial
Read More
Novel anti-HIV agent shows potential as HIV vaccine alternative
Read More
Summit initiates phase Ib modified diet trial of SMT-C1100 for Duchenne muscular dystrophy
Read More
BioNovion and Genmab establish immune oncology collaboration
Read More
Clinical milestone achieved in development of rVSV-EBOV Ebola vaccine candidate
Read More
Tambocor fine granules approved in Japan for pediatric patients
Read More
Midatech Pharma reports preclinical data on OpsiSporin sustained-release treatment for uveitis
Read More
Iconic Therapeutics starts phase II trial of hI-con1 in choroidal neovascularization
Read More
Specific inhibition of NLRP3 shows potential for the treatment of inflammatory diseases
Read More
Pfizer presents RORC2 inhibitors
Read More
New HIV protease inhibitors disclosed by Merck & Co.
Read More
CEPT inhibitors designed at Merck & Co.
Read More
